Promising Strategies for Sickle Cell Disease and β-Thalassemia

Genetic approaches against sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) increased fetal hemoglobin and appeared to improve clinical outcomes in 2 small early trials, researchers reported in the New England Journal of Medicine.
Source: JAMA - Category: General Medicine Source Type: research